MyFinsight
Home
About
Contact
ppcb: the income statement
Download
Download image
Unrealized foreign
currency translation...
$17,044
(117.23%↑ Y/Y)
Total comprehensive
loss
-$4,820,694
(-963.58%↓ Y/Y)
Total other
comprehensive income (loss)
$17,044
(117.23%↑ Y/Y)
Net loss
-$4,837,738
(-1265.40%↓ Y/Y)
Loss before taxes
-$4,837,738
(-1265.40%↓ Y/Y)
Total other income
(expense), net
-$164,174
(-158.46%↓ Y/Y)
Loss from operations
-$4,673,564
(-1507.20%↓ Y/Y)
Gain (loss) on
extinguishment of debt, net
$195,861
(1830.37%↑ Y/Y)
Interest income
$19
(1800.00%↑ Y/Y)
Foreign currency
transaction gain (loss)
-$34,699
(-511.96%↓ Y/Y)
Change in fair value of
derivative liabilities
-$19,706
(-137.33%↓ Y/Y)
Interest expense
$305,649
(254.46%↑ Y/Y)
Total operating
expenses
$4,673,564
(1507.20%↑ Y/Y)
Research and development
$60,201
(-2.45%↓ Y/Y)
Occupancy expenses -
related party
$14,789
(77.82%↑ Y/Y)
Administration expenses
$4,598,574
(1983.07%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Propanc Biopharma, Inc. (PPCB)
Propanc Biopharma, Inc. (PPCB)